Evidence map›Paper›PMID 28188546›Full record

ReviewCurrent reviews in musculoskeletal medicine2017

Osteochondral lesions of the talus in the athlete: up to date review.

Yoshiharu Shimozono, Youichi Yasui, Andrew W Ross, John G Kennedy

Open access · bronzeAbstract readReview
In one paragraph

Review in Current reviews in musculoskeletal medicine, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed, 1 pooled it
2.0field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 1 synthesis or guideline pooled it, 30 citations in OpenAlex.

  1. Guideline
  2. Article
  3. Observational
  4. Review
  5. Article
  6. Finite Element Analysis of the Effect of Talar Osteochondral Defects of Different Depths on Ankle Joint Stability.Medical science monitor : international medical journal of experimental and clinical research · 2020
    Article
  7. Review
  8. Article
  9. Review
  10. Review
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 2 countries.

Yoshiharu ShimozonoHospital for Special Surgery, 523 East 72nd Street, Suite 507, New York, NY, 10021, USA.
Youichi YasuiHospital for Special Surgery, 523 East 72nd Street, Suite 507, New York, NY, 10021, USA.
Andrew W RossHospital for Special Surgery, 523 East 72nd Street, Suite 507, New York, NY, 10021, USA.
John G KennedyHospital for Special Surgery, 523 East 72nd Street, Suite 507, New York, NY, 10021, USA. KennedyJ@hss.edu.
Hospital for Special Surgery · USKyoto University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purpose of reviewOsteochondral lesions of the talus (OLT) are common injuries in athletes. The purpose of this study is to comprehensively review the clinical results and return to sport capacity in athletes following treatment for OLT. RECENT

findingsReparative procedures, such as bone marrow stimulation, and replacement procedures, such as autologous osteochondral transplantation, provide good clinical outcomes in short- and mid-term follow-up in the athlete. Recently, biological augmentation and scaffold-based therapies have been shown to improve clinical and radiological outcomes in OLT in both the general population and athletes. Most studies are of a low level of evidence. Studies analyzing the return to sport capability in athletes are further lacking. High-level evidence and well-designed clinical trials are required to establish the most effective treatment protocol.

Indexed as

Autologous osteochondral transplantationBiologicBone marrow stimulationsOsteochondral lesions of talus

Identifiers

PMID28188546
PMCPMC5344864
OpenAlexW2586989460

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.